Consolidation of the pharmaceutical manufacturing and marketing business into Other due to its declining materiality

As the pharmaceutical manufacturing and marketing business has become less material, its classification will change from an independent reporting segment to Other businesses. It will continue to be disclosed under the revised segment classification.